FDA inspection
Bristol-Myers Squibb Company: FDA inspection ending Apr 21, 2005
FDA inspection 376270 · No Action Indicated (NAI) · Wallingford, CT
Key facts
| Inspection ID | 376270 |
|---|---|
| Firm | Bristol-Myers Squibb Company |
| FEI number | 1283703 |
| Address | 5 Research Pkwy |
| City | Wallingford |
| State | CT |
| ZIP | 06492-1951 |
| Fiscal year | 2005 |
| Inspection end date | Apr 21, 2005 |
| Classification | No Action Indicated (NAI) |
| Project area | Post Mrkt Surv & Epid: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data